- Home
- HMR vs KZR Comparison
HMR vs KZR Comparison
Compare HMR & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HMR | KZR |
|---|---|---|
| Founded | 1984 | 2015 |
| Country | Greece | United States |
| Employees | 57 | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.3M | 54.2M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | HMR | KZR |
|---|---|---|
| Price | $0.90 | $7.36 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | $5.00 | ★ $6.00 |
| AVG Volume (30 Days) | 39.4K | ★ 88.4K |
| Earning Date | 03-24-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $64.04 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.76 | $3.53 |
| 52 Week High | $3.12 | $7.55 |
Technical Indicators
Market Signals| Indicator | HMR | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 53.78 | 62.35 |
| Support Level | $0.87 | $6.06 |
| Resistance Level | $0.96 | N/A |
| Average True Range (ATR) | 0.05 | 0.18 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 66.47 | 89.12 |
Price Performance
Historical ComparisonAbout HMR Heidmar Maritime Holdings Corp.
Heidmar Maritime Holdings Corp is an asset-light tanker pool, and commercial and technical management company. The company is a fast-growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. The company has also recently expanded its business to offer pool management of dry bulk vessels and technical management. The company generates maximum revenue from Singapore.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.